Skip to main content

Table 4 Comparison of clinical findings of patients with MEPE and non-MEPE, peripheral eosinophilia and normal peripheral eosinophil

From: Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study

 

Total (n = 34)

MEPE vs non-MEPE

Peripheral eosinophilia vs normal peripheral eosinophil

MEPE (n = 18)

Non-MEPE (n = 16)

p-Value

Peripheral eosinophilia (n = 9)

Normal peripheral eosinophil (n = 25)

p-Value

Age (y)

56.4 (25–88)

61.7 (44–88)

50.5 (25–83)

0.03

51.7 (25–74)

58.1 (29–88)

0.36

Sex

   

0.774

  

0.70

Male

20 (58.82%)

11 (61.11%)

9 (77.8%)

 

6 (66.7%)

14 (56.0%)

 

Female

14 (41.18%)

7 (38.89%)

7 (22.2%)

 

3 (33.3%)

11 (44.0%)

 

Peripheral blood

WBC (× 109/L)

8.6 (3.2–21.4)

8.5 (3.2–21.4)

8.8 (4.6–16.7)

0.87

10.1 (4.7–16.7)

8.1 (3.2–21.4)

0.04

LYM (× 109/L)

1.3 (0.3–2.5)

1.4 (0.6–2.5)

1.2 (0.3–2.4)

0.26

1.5 (0.3–2.4)

1.2 (0.5–2.5)

0.13

EO (× 106/L)

514.7 (0–5778.0)

394.4 (0–1500.0)

661.2 (0–5778.0)

0.44

1378.0 (600–5778.0)

204.0 (0–500)

 < 0.001

Pleural effusion

LDH (U/L)

369 (90–1402)

449 (172–1402)

280 (90–667)

0.09

437 (128–1126)

345 (90- 1402)

0.51

GLU (mmol/L)

6.07 (3.02–9.77)

6.50 (4.32–9.77)

5.60 (3.02–8.0)

0.12

5.93 (3.02–9.77)

6.12 (3.19–8.34)

0.54

Protein (g/L)

48.0 (27.5–182.9)

55.4 (35.2–182.9)

39.7 (27.5–53.4)

0.07

45.8 (32.8–62.3)

48.8 (27.5–182.9)

0.73

ADA (U/L)

10.4 (0.1–44.7)

8.4 (3.0–29.3)

12.6 (0.1–44.7)

0.24

10.4 (2.8–29.3)

10.4 (0.1–44.7)

0.79

CEA (ng/mL)

106.4 (0.3–2087.0)

199.0 (0.5–2087.0)

2.2 (0.3–4.8)

0.11

24.9 (0.30–162.2)

135.7 (1.0–2087.0)

0.32

WBC (× 109/L)

3.2 (0.1–12.9)

1.8 (0.1–7.67)

4.7 (0.3–12.9)

0.01

5.01 (0.3–12.9)

2.50 (0.1–7.4)

0.10

EO (%)

21.7 (10.0–67.5)

20.6 (10.0–63.0)

22.9 (11.6–67.5)

0.66

31.8 (11.0–67.5)

18.1 (10–46.5)

0.16

RBC (× 109/L)

111.2 (0.2–2986.7)

41.0 (0.2–320)

190.3 (0.2–2986.7)

0.40

27.9 (0.2–216.2)

141.3 (0.2–2986.7)

0.14

  1. Data are presented as the mean (range) or n (%). MEPE malignant eosinophilic pleural effusion, WBC white blood cell, LYM lymphocyte, EO eosinophil, RBC red blood cell, LDH lactate dehydrogenase, ADA adenosine deaminase, GLU glucose, CEA carcinoembryonic antigen